___

• Baum VC, O’Flaherty JE. Zellweger syndrome. In:
• Baum VC, O’Flaherty JE, eds. Anesthesia for Genetic,
• Metabolic and Dysmorphic Syndromes of Childhood.
• Philadelphia, PA: Lippincott Williams& Wilkins, 1999:
• –330.
• Wanders RJA, Waterham HR. Peroxisomal disorders I:
• biochemistry and genetics of peroxisome biogenesis
• disorders. Clin Gen 2004; 67: 107–133.
• Zellweger H, Maertens P, Superneau D, et al. History of
• the cerebrohepatorenal syndrome of Zellweger and other
• peroxisomal disorders. South Med J 1988; 81: 357–364.
• Schwartz RE, Stayer SA, Pasquariello CA, et al.
• Anaesthesia for the patient with neonatal
• adrenoleukodystrophy. Can J Anaesth 1994; 41: 56–58.
• Luciani GB, Pessotto R, Mazzucco A.
• Adrenoleukodystrophy presenting as postperfusion
• syndrome. NEJM 1997; 336: 731–732.
• Platis CM, Kachko L, Peled E, Katz J. Anesthesia for
• the child with Zellweger syndrome: a case report.
• Pediatric Anesthesia 2006;16:361-362.
• Fitzpatrick DR. Zellweger syndrome and associated
• phenotypes. J Med Genet 1996; 33: 863–368.
• Poggi-Travert F, Fournier B, Poll-The BT, et al. Clinical
• approach to inherited peroxisomal disorders. J Inherit
• Metab Dis 1995; 18(S1): 1–18.
• Isık B, Arslan M, Doğan AT, Kurtipek Ö.
• Dexmedetomidine decreases emergence agitation in
• pediatric patients after sevoflurane anesthesia without
• surgery. Paediatr Anesth 2006; 16: 748–753.
• Işık B. Manyetik rezonans görüntüleme ve anestezi.
• Marmara Med J 2006;19:98-103.